Modifi Bio co-founders (from L-R): Kingson Lin, Kevin Rakin, Seth Herzon and Ranjit Bindra
October 23, 2024 07:05 AM EDT
Deals
R&D

Mer­ck pays $30M to buy ‘chameleon’ ap­proach to dead­ly brain can­cers

Lei Lei Wu

News Reporter

Mer­ck is ac­quir­ing a start­up spun out of Yale called Mod­i­fi Bio, which has de­vel­oped a suite of mol­e­cules against chemother­a­py-re­sis­tant glioblas­toma, a dev­as­tat­ing and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times